Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-006938
Filing Date
2025-11-04
Accepted
2025-11-04 07:05:03
Documents
2
Period of Report
2025-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_110425.htm 6-K 5946
2 PRESS RELEASE exh_991.htm EX-99.1 481171
  Complete submission text file 0001171843-25-006938.txt   488331
Mailing Address 919 11 AVENUE SW SUITE 300 CALGARY Canada (Federal Level)
Business Address 919 11 AVENUE SW SUITE 300 CALGARY Canada (Federal Level) 14039485227
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 251446400
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)